Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study (Q38440892)

3 September 2017

title

Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study (English)

1 reference

3 September 2017

1 reference

1 reference

1 reference

David R Williams

1

0 references

Andrew John Lees

series ordinal

2

object named as

Andrew J Lees

1 reference

3 September 2017

publication date

1 October 2005

1 reference

3 September 2017

1 reference

3 September 2017

volume

4

1 reference

3 September 2017

issue

10

1 reference

3 September 2017

page(s)

605-610

1 reference

Behavioral complications of drug treatment of Parkinson's disease

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Diffuse Lewy body disease in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Diagnostic criteria for corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Consensus statement on the diagnosis of multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Hallucinosis in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Hallucinations in Parkinson's disease: a follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Prospective study of hallucinations and delusions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Motor impairment in PD: relationship to incident dementia and age.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970146-0

7 January 2021

10.1016/S1474-4422(05)70146-0

Identifiers

DOI

1 reference

3 September 2017

1 reference